Assessment of the circulating klotho protein in lung cancer patients

J. Pako, A. Bikov, I. Barta, H. Matsueda, R. Puskas, G. Galffy, A. Kerpel-Fronius, B. Antus, I. Horvath

Research output: Contribution to journalArticlepeer-review


The anti-aging factor, klotho has been identified as a tumor suppressor in various human cancers, including lung cancer. In vitro studies provided evidence that klotho expression influences the characteristics of lung cancer cells, however, in vivo results are lacking. The aim of our study was to evaluate whether circulating klotho protein might serve as a potential biomarker of lung cancer. Blood samples were taken from 45 newly diagnosed lung cancer patients (31 NSCLC, 14 SCLC) and 43 control subjects. Plasma klotho concentration was measured using ELISA. No difference in plasma klotho values was detected between patients and control subjects (366.3 (257.9–486.8) vs. 383.5 (304.6–489.7) pg/ml respectively (median (IQR)); p > 0.05). Plasma klotho levels in patients with distant metastasis did not differ from less advanced stage disease (354.2 (306.9–433.3 vs. 328.5 (242.5–419.7) pg/ml, p > 0.05). In contrast, analyzed with one-way ANOVA, significant difference (p = 0.04) was found between the examined histological types of lung cancer: adenocarcinoma (353 (329.4–438.5) pg/ml), squamous cell carcinoma (308 (209.6–348.1) pg/ml) and small cell lung cancer (388.8 (289.9–495.4) pg/ml). However, Tukey’s post hoc test did not reveal significant difference between any pairs of histological groups. There was no difference between any histological subtype and health either. Our results suggest that circulating klotho protein cannot be considered as a biomarker for lung cancer. Further studies are warranted in order to examine the relationship between klotho expression in lung tissue and circulating levels of the protein, and to explore its mechanism of action in lung cancer. © 2018 Arányi Lajos Foundation
Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalPathology and Oncology Research
Early online date12 Jun 2018
Publication statusPublished - 2018


  • Biomarkers
  • Insuline-like growth factor 1
  • Lung cancer
  • Premature aging
  • Tumor suppressor


Dive into the research topics of 'Assessment of the circulating klotho protein in lung cancer patients'. Together they form a unique fingerprint.

Cite this